Biogen, Inc. (BIIB)

172.62 +7.24 (+4.38%) USD  |  NASDAQ  |  Jan 21, 16:00
172.78 +0.16 (+0.09%) Pre-Market: 08:08
More

Biogen Extraordinary Items, Income Statement (Quarterly)

Extraordinary Items, Income Statement (Quarterly) Chart

View Extraordinary Items, Income Statement (Quarterly) for BIIB.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Extraordinary Items, Income Statement (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Extraordinary Items, Income Statement (Quarterly) Range, Past 5 Years

View Extraordinary Items, Income Statement (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Extraordinary Items, Income Statement (Quarterly) Benchmarks

View Extraordinary Items, Income Statement (Quarterly) Benchmarks
Start Trial
Eli Lilly & Co. Upgrade
AbbVie, Inc. Upgrade
Stoke Therapeutics, Inc. Upgrade
Alnylam Pharmaceuticals, Inc. Upgrade
Insmed, Inc. Upgrade